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OBJECTIVES We sought to determine whether clinical risk stratification correlates with the angiographic
extent of coronary artery disease (CAD) in patient with unstable angina.
BACKGROUND The Agency for Health Care Policy and Research (AHCPR) guidelines stratify patients with
unstable angina according to short-term risk of myocardial infarction or death. Whether these
guidelines are useful in predicting the extent of CAD is unknown.
METHODS All residents of Olmsted County, Minnesota, undergoing emergency department evaluation
from January 1, 1985 through December 31, 1992 for unstable angina without a history of
prior coronary artery bypass grafting, and who underwent early angiography (within seven
days of presentation) were classified into low, intermediate and high risk subgroups based on
AHCPR criteria.
RESULTS Seven hundred ninety-five patients underwent early angiography: 159 high risk, 572
intermediate risk and 64 low risk patients. Logistic regression analysis demonstrated that low
risk patients had a greater likelihood of normal or mild CAD relative to intermediate risk
(odds ratio [OR], 4.67; 95% confidence interval [CI], 2.70–8.06; p , 0.001) and high risk
(OR, 11.1; 95% CI, 5.71–22.2; p , 0.001). Significant 1-, 2-, 3-vessel coronary disease or left
main coronary disease was more likely in high relative to low risk (OR, 8.09; 95% CI,
4.22–15.5; p , 0.001), intermediate relative to low risk (OR, 4.11; 95% CI, 2.34–7.22;
p , 0.001), and high relative to intermediate risk (OR, 1.97; 95% CI, 1.31–2.96; p 5
0.0012).
CONCLUSIONS Among patients with unstable angina undergoing early coronary angiography, risk stratifi-
cation according to the AHCPR guidelines correlates with the angiographic extent of CAD.
(J Am Coll Cardiol 2001;37:2053–8) © 2001 by the American College of Cardiology
The evaluation and management of patients with unstable
angina is an important clinical issue; in the U.S. alone, there
are approximately 850,000 hospital admissions for unstable
angina annually. Determining the prognosis of patients with
unstable angina is hampered by a wide variation in the
definition of unstable angina, duration of follow up and
treatment differences.
In 1994, the Agency for Health Care Policy and Research
(AHCPR) published a definitive guideline for the diagnosis
and management of unstable angina (1). In a stepwise
approach, the guideline stratifies patients with unstable
angina into low, intermediate and high risk subgroups,
according to the likelihood of coronary artery disease
(CAD) and the short-term risk of myocardial infarction
(MI) or death. The AHCPR guidelines have been validated
in a population-based registry with regard to short-term
prognosis (2). However, whether these guidelines are useful
in predicting the presence and degree of CAD as assessed by
coronary angiography is unknown. If it could be shown that
risk stratification based on clinical (AHCPR) criteria cor-
relates with angiographic coronary disease in addition to
prognosis, this could provide a useful method for determin-
ing which patients with unstable angina may be suitable for
early coronary intervention.
Therefore, we reviewed our population-based database to
determine whether the presence and degree of CAD corre-
late with short-term cardiovascular risk according to AH-
CPR guidelines in patients presenting with unstable angina
undergoing coronary angiography early in their evaluation.
METHODS
Patient population. The study retrospectively identified all
residents of Olmsted County, Minnesota presenting to one
of the county’s three emergency departments with acute
chest pain during the period January 1, 1985 through
December 31, 1992. The complete medical records of this
population were reviewed by an experienced nurse abstracter
who identified the subset of patients from this group who
had symptoms consistent with an unstable coronary syn-
drome. This was defined according to the Diamond classi-
fication as follows: new onset or a worsening pattern of
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ischemic chest pain (anterior or left lateral) occurring at rest
or with minimal exertion and alleviated by sublingual
nitroglycerin and/or rest (3).
Patients were excluded if they had ST-segment elevation
indicative of acute MI on their baseline electrocardiogram
(ECG), new left bundle branch block or a definitive
nonischemic etiology for their chest pain at the time of
presentation.
Data collection. For all eligible patients, the medical
record was abstracted, including the history and detailed
physical examination findings at the qualifying episode, as
well as past medical history. This was carried out utilizing
the resources of the Rochester Epidemiology Project, which
allows capture of the health care experience of all residents
of Olmsted County, Minnesota (4). Patients undergoing
early angiography (#7 days of their index emergency
department visit) were identified. Using the AHCPR cri-
teria for the short-term risk of MI and/or death, patients
were retrospectively classified based on their initial emer-
gency department presentation information into low, inter-
mediate and high risk subgroups (see Definitions section).
DEFINITIONS
Low risk according to AHCPR criteria was defined as at
least one of the following: increased angina frequency,
severity or duration; angina provoked at a lower threshold;
new onset angina within two weeks to two months; with
normal or unchanged ECG (with no high risk or interme-
diate risk features present). Intermediate risk was defined as
at least one of the following: rest angina that had resolved;
rest angina of .20 min duration relieved with sublingual
nitroglycerin; angina with dynamic T-wave changes; noc-
turnal angina; new-onset Canadian Cardiovascular Society
class III or IV angina in the past two weeks; Q-waves or
ST-depression ,1 mm in multiple leads; or age .65 years
(and no high risk features present). High risk was defined as
at least one of the following: prolonged ongoing rest pain;
pulmonary edema; angina with new or worsening mitral
regurgitation murmur; rest angina with dynamic ST-
changes $1 mm; angina with S3 or rales; or angina with
hypotension.
A history of CAD was determined based on symptoms
and/or prior abnormal results of functional test, a history of
MI or a history of prior coronary angiography demonstrat-
ing at least moderate coronary disease. A history of vascular
disease included a history of CAD (as above), cerebrovascu-
lar disease including transient ischemic attack or stroke, or
symptomatic or asymptomatic peripheral vascular disease.
Myocardial infarction was considered to have occurred when
at least two of the following three criteria were met: 1) chest
pain .30 min; 2) persistent electrocardiographic changes
suggestive of ischemia; or 3) greater than or equal to twofold
elevations in serum creatine kinase levels with elevation of
the MB isoform.
The degree of CAD as determined by angiography was
classified as follows: 1) normal coronary angiogram; 2) mild
CAD (,50% stenosis in one or more epicardial vessels); 3)
moderate CAD $50% stenosis but ,70% stenosis in one or
more epicardial vessels); 4) significant single-vessel CAD
($70% stenosis in one major epicardial vessel); 5) signifi-
cant two-vessel CAD ($70% stenosis in two major epicar-
dial vessels); 6) significant three-vessel CAD ($70% steno-
sis in all three major epicardial vessels); or 7) significant left
main CAD ($50% stenosis of the left main coronary artery)
(5).
Statistical analysis. Logistic regression analysis was used
to assess the correlation between the AHCPR risk profile
and the presence and degree of CAD. Results are presented
as odds ratios (ORs) with corresponding 95% confidence
intervals (CIs). Additionally, sensitivity, specificity, positive
and negative predictive values to correlate the degree of
CAD with AHCPR risk grouping were performed. Spear-
man’s rank correlation was used to test the correlation
between a calculated myocardial jeopardy score (6) and the
AHCPR risk categories.
RESULTS
Of the 6,801 residents of Olmsted County presenting to
emergency departments for acute chest pain during the
study period, 2,282 (33.4%) met eligibility criteria for
unstable angina. Of these, 435 patients (19.1%) were
classified as high risk, 1,562 patients (68.4%) were classified
as intermediate risk and 285 patients (12.5%) were classified
as low risk based on AHCPR guidelines. Of these 2,282
patients, 795 patients who underwent early angiography and
without prior coronary artery bypass grafting (CABG)
comprise the study cohort. Of patients referred for early
angiography, 159 patients (20%) were classified as high risk,
572 patients (72%) were classified as intermediate risk and
64 patients (8%) were identified as low risk (Table 1). High
risk patients were more likely to be older, with a prior
history of CAD and MI, congestive heart failure and
coronary revascularization. The incidence of hypercholes-
terolemia, diabetes and hypertension increased with higher
AHCPR risk. High risk unstable angina patients were also
more likely to have their conditions evolve into a non-ST-
elevation MI during the first 24 h of hospitalization. The
rates of coronary revascularization during the index hospi-
Abbreviations and Acronyms
AHCPR 5 Agency for Health Care Policy and Research
CABG 5 coronary artery bypass grafting
CAD 5 coronary artery disease
CI 5 confidence interval
ECG 5 electrocardiogram
FRISC 5 Fragmin and fast Revascularization during
InStability of Coronary artery disease
MI 5 myocardial infarction
OR 5 odds ratio
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talization also increased in frequency with higher AHCPR
risk profile.
A normal coronary angiogram or mild CAD was most
frequent in the low risk subgroup (Table 2). Although
significant single-vessel disease was noted among 18.8% of
low risk patients undergoing angiography, the frequency of
multivessel disease, particularly three-vessel disease or left
main CAD, was low. Conversely, among patients at inter-
mediate or high risk, the incidence of multivessel disease
was high, with three-vessel or left main CAD occurring in
14.2% of intermediate risk patients and 21.4% of high risk
patients undergoing angiography. Moreover, significant 1-,
2-, 3-vessel, or left main CAD was present in 63.5% of
intermediate risk patients and 77.4% of high risk patients
undergoing angiography.
When excluding patients with normal coronary arteries or
mild CAD, the AHCPR risk grouping no longer correlated
with the extent of significant CAD (Table 3).
Logistic regression. Logistic regression analysis demon-
strated that low risk patients had a greater likelihood of
having angiographically normal coronary arteries or mild
CAD relative to intermediate risk (OR, 4.67; 95% CI,
2.70–8.06; p , 0.001) and high risk (OR, 11.2; 95% CI,
5.71–22.2; p , 0.001). The presence of three-vessel coro-
nary artery disease or left main CAD was associated with
increasing AHCPR risk group (high risk relative to inter-
mediate risk group OR, 1.65; 95% CI, 1.06–2.58; p 5
0.028; intermediate risk relative to low risk group OR, 5.11;
95% CI, 1.23–21.3; p 5 0.025; and high risk relative to low
risk OR, 8.43; 95% CI, 1.96 to 36.2; p 5 0.004). The presence
of significant 1-, 2-, 3-vessel coronary disease or left-main
CAD also correlated to increasing AHCPR risk grouping
(high relative to intermediate risk group OR, 1.97; 95% CI,
1.31–2.96; p 5 0.0012; intermediate relative to low risk group
OR, 4.11; 95% CI, 2.34 to 7.22; p , 0.001; and high relative
to low risk group OR, 8.09; 95% CI, 4.22–15.5; p , 0.001).
Table 1. Early Angiography: Patients and Demographics
Low Risk
(n 5 64)
Intermediate Risk
(n 5 572)
High Risk
(n 5 159) p Value
Age of patient (yr) 51.0 6 9.4 61.1 6 12.8 64.0 6 13.6 , 0.00001
Male 40 (62.5) 387 (67.7) 105 (66.0) 0.68
History of MI 0 (0.0) 92 (16.1) 35 (22.0) 0.0003
History of CHF 0 (0.0) 33 (5.8) 31 (19.5) , 0.00001
History of PTCA 0 (0.0) 34 (5.9) 10 (6.3) 0.13
History of CAD 0 (0.0) 144 (25.2) 61 (38.4) , 0.00001
History of vascular disease 1 (1.6) 204 (35.7) 72 (45.3) , 0.00001
Never smoked 28 (43.8) 220 (38.5) 58 (36.5) 0.60
Current smoker (past 3 yr) 15 (23.4) 138 (24.1) 41 (25.8) 0.90
Cholesterol $240 34 (53.1) 392 (68.5) 105 (66.0) 0.045
Diabetes 3 (4.7) 84 (14.7) 33 (20.8) 0.009
Hypertension 13 (20.3) 262 (45.8) 77 (48.4) 0.0003
MI at index presentation 11 (17.5) 169 (29.6) 98 (61.6) , 0.00001
Mean time from ED admission date to
angiogram (days)
1.5 6 1.4 1.9 6 1.6 1.9 6 2.0 0.610
Jeopardy score 2.7 6 5.1 6.8 6 7.6 9.1 6 8.2 , 0.00001
Percutaneous revascularization during
index hospitalization
6 (9.4) 170 (29.7) 58 (36.5) 0.0003
CABG during index hospitalization 5 (7.8) 95 (16.6) 32 (20.1) 0.08
Percutaneous revascularization or CABG
during index hospitalization
11 (17.2) 265 (46.3) 90 (56.6) , 0.00001
The numbers in parentheses are percentages of the total in each group.
CABG 5 coronary artery bypass grafting; CAD 5 coronary artery disease; CHF 5 congestive heart failure; ED 5 emergency
department; MI 5 myocardial infarction; PTCA 5 percutaneous transluminal coronary angioplasty.
Table 2. Angiographic Results by Agency for Health Care Policy and Research Risk Group
Low Risk
(n 5 64)
Intermediate Risk
(n 5 572)
High Risk
(n 5 159) p Value
Normal angiogram 23 (35.9) 67 (11.7) 12 (7.5) ,0.00001
Mild CAD 19 (29.7) 99 (17.3) 11 (6.9) 0.0001
Moderate CAD 3 (4.7) 42 (7.3) 13 (8.2) 0.66
Significant 1-vessel CAD 12 (18.8) 177 (30.9) 51 (32.1) 0.11
Significant 2-vessel CAD 5 (7.8) 105 (18.4) 38 (23.9) 0.020
Significant 3-vessel CAD 1 (1.6) 44 (7.7) 21 (13.2) 0.011
Significant left main CAD 1 (1.6) 37 (6.5) 13 (8.2) 0.19
1-, 2-, 3-vessel or left main CAD 19 (29.7) 363 (63.5) 123 (77.4) ,0.00001
3-vessel or left main CAD 2 (3.1) 81 (14.2) 34 (21.4) 0.0018
The numbers in parentheses are percentages of the total in each group.
CAD 5 coronary artery disease.
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The sensitivity and specificity of high risk classification
correlating with significant 1-, 2-, 3-vessel or left main
CAD was 24% and 88%, respectively, with positive and
negative predictive values of 77% and 40%, respectively.
Combining high and intermediate risk subgroups increased
the sensitivity to 96%, but decreased the specificity to 16%,
whereas positive and negative predictive values were 66%
and 70%, respectively. It should be noted that predictive
values are dependent on disease prevalence in the index
population, and it is possible that the prevalence for CAD is
higher in patients who were selected to undergo angiogra-
phy than in those who were not and, therefore, these results
should be interpreted accordingly.
Among the patients undergoing angiography, the mean
myocardial jeopardy score correlated with the AHCPR risk
categories. Low risk patients had a mean score of 2.7 6 5.1,
intermediate risk patients had a score of 6.8 6 7.6 and high
risk patients had a score of 9.1 6 8.2 (r 5 0.19, p , 0.001).
DISCUSSION
The current study demonstrates that among patients pre-
senting with unstable angina who are referred for coronary
angiography, clinical risk stratification according to
AHCPR guidelines correlates with the angiographic extent
of CAD. Specifically, normal coronary arteries or mild
CAD were more likely to be seen in low risk patients,
whereas significant CAD (1-, 2-, 3-vessel, or left main
CAD) was more likely to be observed in intermediate and
high risk patients. This clinical risk stratification also
correlates with the previously reported method of assessing
the burden of CAD (myocardial jeopardy score) (6).
Risk stratification in unstable angina. Accurate determi-
nation of the short-term prognosis of the individual patient
presenting with unstable angina is hampered by the wide
variability in the definition of unstable angina and treatment
modalities employed in earlier studies. However, the im-
portance of risk stratification of patients with unstable
angina has increasingly been recognized. The AHCPR
guidelines were published in 1994, outlining steps for the
diagnosis, risk stratification and management of patients
presenting with unstable angina (1). The validity of these
guidelines with respect to predicting short-term prognosis
of patients presenting with unstable angina has been dem-
onstrated (2). Interestingly, it has also been shown that the
AHCPR risk profile correlates with long-term prognosis as
well, such that event-free survival is lower with increasing
AHCPR risk group (7). Therefore, prompt identification of
patients at increased risk may guide appropriate treatment,
possibly impacting both short- and long-term outcome.
Early invasive strategy for unstable angina. Significant
controversy exists with respect to the use of an early invasive
strategy in the assessment of patients presenting with
unstable angina. Although early coronary angiography is
frequently utilized in the U.S., significant regional as well as
intercountry variations exist in practice, primarily dictated
by physician preferences, patient expectations, as well as the
availability of catheterization facilities (8–12). Numerous
previous studies have demonstrated either no benefit (12,13)
or even a detrimental effect (14) on the rates of death or MI
in patients with non-ST-elevation acute coronary syn-
dromes undergoing an early invasive strategy. Potential
explanations for the lack of any observed benefit include
high rates of crossover from the noninvasive to the invasive
arms, with convergent rates of angiography and subsequent
coronary revascularization between the two treatment
groups over time. As such, the relative benefit of one
strategy versus another may not be apparent during short- or
intermediate-term follow up. In addition, these studies were
not designed to test the concept of risk stratification and,
therefore, are unable to answer the question as to whether
certain subsets of patients are more or less likely to benefit
from an early invasive strategy. We have recently demon-
strated that an early invasive strategy (coronary angiography
performed within seven days of index presentation) was
associated with a significant survival benefit during the
course of long-term follow up in the intermediate and
high risk patients, but not low risk patients, according to
AHCPR guidelines (15). These findings are in accord with
the recently published Fragmin and Fast Revascularization
during Instability of Coronary artery (FRISC) II trial,
which demonstrated that early coronary angiography pre-
ceded by pretreatment with low molecular weight heparin,
was associated with a significant reduction in death or MI
with up to 1 year of available follow up (16). Taken in total,
the available data suggest that there are subsets of patients
who are likely to benefit from an early invasive strategy;
Table 3. Angiographic Results by Agency for Health Care Policy and Research Risk Group
Excluding Normal Angiograms and Mild CAD Patients
Variable
Low Risk
(n 5 22)
Intermediate Risk
(n 5 406)
High Risk
(n 5 136) p Value
Moderate CAD 3 (13.6) 42 (10.3) 13 (9.6) 0.84
Significant 1-vessel CAD 12 (54.5) 177 (43.6) 51 (37.5) 0.24
Significant 2-vessel CAD 5 (22.7) 105 (22.9) 38 (27.9) 0.83
Significant 3-vessel CAD 1 (4.4) 44 (10.8) 21 (15.4) 0.20
Significant left main CAD 1 (4.5) 37 (9.1) 13 (9.6) 0.75
1-, 2-, 3-vessel or left main CAD 19 (86.4) 363 (89.4) 123 (90.4) 0.83
3-vessel or left main CAD 2 (9.1) 81 (20.0) 34 (25.0) 0.18
Numbers in parentheses are percentage of the total.
CAD 5 coronary artery disease.
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similarly, there are patients who are unlikely to benefit from
an early invasive strategy. The concept of risk stratification,
therefore, is crucially important to identifying these respec-
tive subgroups.
Effect of coronary revascularization on survival. It has
been clearly demonstrated that surgical coronary revascular-
ization is associated with improved long-term survival in
certain subsets of patients, that is, those with severe 3-vessel
coronary disease or left main CAD (17–19). Although the
current study does not include a large proportion of patients
with such “high risk” anatomy, 3-vessel disease or LMCA
disease accounted for a significant minority of patients in
the intermediate and high risk categories (19% and 26.2%,
respectively). In large part, the data regarding the survival
benefit in these subgroups apply to those patients with
chronic ischemic heart disease, although the Veterans Ad-
ministration study of unstable angina demonstrated an early
survival advantage (which disappeared by 10 years of follow-
up) with surgical revascularization as compared to medical
therapy in patients with unstable coronary syndromes and
reduced left ventricular ejection fraction (20). However, we
have shown that coronary revascularization, either percuta-
neous or surgical, during the index hospital admission for
unstable angina, is associated with significant long-term
survival benefit (15). Additionally, the FRISC II trial
demonstrates improved survival free of MI in patients with
unstable angina undergoing early angiography with a high
rate of coronary revascularization (16). Therefore, there
appears to be an increasing body of evidence to suggest that
early revascularization in patients with acute non-ST-
elevation coronary syndromes may also be associated with
improved event-free survival. As such, early identification of
patients with unstable angina and significant CAD may be
important, since these patients appear to be most likely to
benefit from an early invasive strategy leading to coronary
revascularization. The AHCPR risk classification scheme
appears to be useful in this regard, insofar as 65% of
intermediate risk patients have significant (1-, 2-, 3-vessel,
or left main) disease whereas 77% of high risk patients
demonstrated angiographic evidence of significant coronary
disease. When excluding patients with normal coronary
angiograms or mild CAD, the AHCPR risk grouping no
longer correlated with the extent of CAD on angiography.
This is certainly in keeping with the fact that increasing
AHCPR risk profile is associated with a much lower
likelihood of insignificant CAD; indeed, most patients who
were low risk had normal coronary angiograms or mild
CAD, whereas only 14.5% of high risk patients had insig-
nificant CAD.
The fact that significant coronary disease was noted in 19
low risk patients (29.7% of low risk patients undergoing
angiography and 6.6% of all low risk patients) warrants
further examination. Of these patients, 11 patients went on
to have their conditions evolve into MI based on elevated
serial serum creatine phosphokinase levels, as well as serial
ECGs. Thus, although it has been previously stated that
low risk patients have relatively low event rate and therefore
can be dismissed safely from the emergency department
based on clinical criteria, these data would suggest that an
observation period in a facility such as an emergency
department-based chest pain unit with subsequent determi-
nation of cardiac enzyme levels 6 to 8 h after initial
presentation may be reasonable in these patients. This may
potentially reduce the rate of missed MI in the emergency
department setting, which would have been 3.9% in this
study (11 of 285 low risk patients) if they had been
dismissed directly from the emergency department setting.
A routine invasive strategy in low risk patients at present
does not appear to be justified; additionally, such a strategy
is not cost favorable (21). However, the addition of cardiac
markers to the clinical risk stratification scheme may guide
the appropriate utilization of an early invasive strategy in
low risk patients as well.
STUDY LIMITATIONS
This study is limited by the biases innate to a retrospective
registry review. The retrospective application of the AHCPR
guidelines to data present in the medical record may or may
not be as accurate as prospective use of these guidelines.
Referral for coronary angiography was at the discretion of
the attending cardiologist, and we have previously demon-
strated differences in baseline characteristics between those
patients referred for coronary angiography versus those who
were not. We excluded patients with prior CABG, since the
myocardial jeopardy score has not been validated in this
population of patients. These results apply to the population
of patients with unstable angina referred for angiography
from this dataset, but may not necessarily apply to the entire
population of patients with unstable angina presenting for
emergency room department evaluation.
CONCLUSIONS
The current study demonstrates that among patients with
unstable angina who are referred for early coronary angiog-
raphy, risk stratification according to the AHCPR guide-
lines correlates with the angiographic extent of CAD, such
that intermediate and high risk patients have a high likeli-
hood of angiographically significant coronary disease.
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